Company Description
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States.
The company offers nebulizers; invasive ventilation; and home medical equipment, such as stair lifts, ramps, bath safety equipment, daily living, and ambulatory, as well as home modification solutions.
It also engages in the rental and sale of medical equipment and related devices. In addition, the company offers solutions that supports patients dealing with heart and pulmonary disease, sleep apnea, reduced mobility, COPD, neuromuscular disorders, obesity, and other chronic health conditions.
The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021.
Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
| Country | United States |
| Founded | 1993 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,200 |
| CEO | Gregory Crawford |
Contact Details
Address: 1019 Town Drive Wilder, Kentucky 41076 United States | |
| Phone | 859 878 2220 |
| Website | quipthomemedical.com |
Stock Details
| Ticker Symbol | QIPT |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001540013 |
| CUSIP Number | 74880P104 |
| ISIN Number | CA74880P1045 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Gregory J. Crawford | Chairman, President and Chief Executive Officer |
| Hardik Mehta | Chief Financial Officer |
| David Bachelder | Executive Vice President of Operations |
| William Todd Zehnder | Chief Strategy Officer and Investor Relations |
| Cole Stevens | Vice President of Corporate Development and VP of Investor Relations |
| Mark Miles | Vice President of Information Technology |
| Thomas W. Roehrig | Executive Vice President of Finance |
| Patrick Dennis Gamble | Executive Vice President of Operations |
| Robert Grossman LLB | Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 10, 2025 | 10-Q | Quarterly Report |
| Feb 10, 2025 | 8-K | Current Report |
| Feb 4, 2025 | SCHEDULE 13G/A | Filing |
| Feb 3, 2025 | 8-K | Current Report |
| Jan 31, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jan 29, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jan 28, 2025 | SCHEDULE 13D/A | Filing |
| Jan 27, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jan 24, 2025 | ARS | Filing |
| Jan 24, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |